Dr Gareth Rivalland on promising trial of melanoma vaccine
A deeply compelling innovation has cancer specialists buzzing. An experimental mRNA cancer vaccine which has allowed people with high-risk melanoma to live longer, cancer-free, according to drug companies Moderna and Merck. Medical Oncologist and Melanoma NZ Spokesperson Gareth Rivalland has been leading this from the New Zealand end joined Guyon Espiner to discuss.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.